In breast cancer, low expressions of BTN1A1, BTN2A1, BTN2A2, BTN2A3, BTN3A1, BTN3A2, BTN3A3, BTNL2, BTNL3, and BTNL9 were significantly correlated with worse OS (Figure 5C). Here, BTN3A3 is linked to breast carcinoma.